Zeitschrift für Palliativmedizin, published by GEORG THIEME VERLAG KG, is a leading journal dedicated to the field of palliative medicine. With its focus on improving the quality of life for patients with severe illnesses, this journal serves as an essential platform for researchers, healthcare professionals, and students interested in the latest developments, practices, and innovations in palliative care. While it does not currently offer open access options, Zeitschrift für Palliativmedizin is committed to disseminating high-quality, peer-reviewed research that advances the understanding and implementation of palliative care strategies. Situated in Stuttgart, Germany, this journal aims to bridge the gap between clinical practice and research, facilitating the exchange of knowledge that enhances patient care and support. As the field continues to grow in importance, this journal stands out as an invaluable resource for those dedicated to improving patient outcomes and advancing the discourse in palliative medicine.

PROGRESS IN PALLIATIVE CARE, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing the field of palliative care through high-quality research and innovative practices. With an ISSN of 0969-9260 and an E-ISSN of 1743-291X, this journal serves as a critical resource for healthcare professionals, researchers, and students seeking to enhance their understanding of pain management, symptom relief, and holistic care approaches for patients with life-limiting illnesses. Operating without an open access model, the journal is well-regarded in the academic community, holding a Q3 ranking in Medicine (miscellaneous) and a Q2 ranking in Nursing (miscellaneous) as of 2023. Its Scopus ranking places it at rank #51 out of 139 in General Nursing, reflecting its relevance and quality within the field. Covering the period from 2001 to 2024, it aims to foster interdisciplinary dialogue and share vital research findings to improve palliative care practices, ultimately enhancing patient care and outcomes.

Palliative & Supportive Care, published by Cambridge University Press, is a pivotal journal dedicated to advancing research and practice in the fields of palliative care, supportive care, and the psychological aspects of terminal and chronic illness. With a robust ISSN of 1478-9515 and an E-ISSN of 1478-9523, this esteemed journal has established itself as a vital resource for professionals, researchers, and students who are committed to improving the quality of life for patients facing serious health challenges. Featuring peer-reviewed articles that span clinical psychology, medicine, nursing, and psychiatry, it holds a respectable impact factor, ranking Q2 in Clinical Psychology, Medicine, and Nursing as per the 2023 category quartiles. The journal is based in the United Kingdom and has been contributing to the field since its inception in 2003. Although it currently does not offer Open Access, its rigorously curated content underscores its relevance and importance in facilitating interdisciplinary dialogue and innovation in palliative and supportive care. For those seeking to stay at the forefront of research, Palliative & Supportive Care remains an indispensable platform for scholarly communication and discovery.

Neuro-Oncology Practice is a leading journal in the interdisciplinary field of neuro-oncology, published by Oxford University Press. With an ISSN of 2054-2577 and E-ISSN 2054-2585, this journal provides a critical platform for the dissemination of cutting-edge research and clinical advancements since its inception in 2014. As of 2023, it has achieved a Q2 ranking in Medicine (Miscellaneous), Neurology, and Oncology categories, reflecting its esteemed position in the academic community with impressive Scopus rankings, including a 74th percentile in the field of Medicine. Despite its non-open access status, Neuro-Oncology Practice aims to bridge the gap between laboratory research and clinical practice, offering valuable insights for professionals involved in the treatment and study of neurological cancers. The journal actively encourages submissions that explore innovative treatment strategies, enhance patient care, and advance our understanding of the complexities surrounding brain tumors. With a convergence period extending to 2024, it remains a crucial resource for researchers, practitioners, and students who are committed to improving outcomes in the field of neuro-oncology.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.

Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.

International Journal of Palliative Nursing is a renowned peer-reviewed journal dedicated to advancing the field of palliative care and nursing. Published by MA HEALTHCARE LTD in the United Kingdom, this journal has been a pivotal resource for healthcare professionals, researchers, and students alike since its inception in 2000. With an ISSN of 1357-6321, it is well-regarded for its commitment to high-quality research and practical insights, maintaining a Q3 category ranking in Advanced and Specialized Nursing. Despite its non-open access format, the journal offers a wealth of knowledge through a diverse array of articles that cover the latest advancements and best practices in palliative nursing. Its Scopus Rank at #36/63 reflects its respectable standing in the nursing community and highlights its contributions to the interdisciplinary realm of palliative care. The journal is an invaluable platform for fostering dialogue and sharing innovative approaches to nurture compassionate patient care.

Medecine Palliative is a distinguished journal published by Elsevier, dedicated to the vital field of palliative care and pain management. With an ISSN of 1636-6522 and E-ISSN 2213-0098, this international journal has been an essential resource since its inception in 1970, currently covering research from 2004 to 2024. The journal reflects a commitment to enhancing the quality of life for patients facing serious illnesses, addressing critical issues in Anesthesiology and Oncology, while fostering innovative nursing practices in palliative care. While the journal holds a Q3 ranking in Anesthesiology and Pain Medicine and a Q4 in Oncology categories, making it a valuable venue for researchers and practitioners aiming to contribute to the evolving landscape of palliative medicine. Despite its lower rank in some categories, the journal serves as an important platform for insights, clinical findings, and current practices that can significantly impact patient care. Medecine Palliative is accessible to researchers, professionals, and students who are eager to explore the latest advancements and evidence-based approaches in end-of-life care.

Journal of Cancer Policy is an esteemed publication devoted to the critical intersection of health policy and oncology. Published by Elsevier Sci Ltd in the United Kingdom, this journal has been a pivotal platform since its inception in 2013, contributing to the field's discourse on cancer management and policy-making strategies. With an impressive Q2 ranking in both the Health Policy and Oncology categories for 2023, it underscores its significance in shaping policy frameworks that address the complexities of cancer care. The journal is listed in Scopus with a respectable rank of #177 in Health Policy and #261 in Oncology, indicating its broad reach and impactful contributions to research and scholarly discussions. While the journal operates under a subscription model, it aims to provide readers with high-quality research that can influence health decisions and policy formation. As a vital resource for researchers, healthcare professionals, and students alike, the Journal of Cancer Policy plays a fundamental role in advancing the understanding of how policies can improve cancer outcomes and healthcare systems.